BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15704612)

  • 1. Interactions between clarithromycin and digoxin in patients with end-stage renal disease.
    Hirata S; Izumi S; Furukubo T; Ota M; Fujita M; Yamakawa T; Hasegawa I; Ohtani H; Sawada Y
    Int J Clin Pharmacol Ther; 2005 Jan; 43(1):30-6. PubMed ID: 15704612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of clarithromycin-induced digoxin toxicity.
    Guerriero SE; Ehrenpreis E; Gallagher KL
    Pharmacotherapy; 1997; 17(5):1035-7. PubMed ID: 9324195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.
    Chan AL; Wang MT; Su CY; Tsai FH
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1237-43. PubMed ID: 19655133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin-induced digoxin intoxication.
    Laberge P; Martineau P
    Ann Pharmacother; 1997 Sep; 31(9):999-1002. PubMed ID: 9296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digitalis intoxication secondary to treatment with clarithromycin].
    Bonilla Porras M; Lucena Campillo MA; Delgado Silveira E; Ramallal Jiménez Del Llano MC; García Díaz B
    Farm Hosp; 2005; 29(3):209-13. PubMed ID: 16013947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature.
    Xu H; Rashkow A
    Conn Med; 2001 Sep; 65(9):527-9. PubMed ID: 11678058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin induced digoxin toxicity.
    Nordt SP; Williams SR; Manoguerra AS; Clark RF
    J Accid Emerg Med; 1998 May; 15(3):194-5. PubMed ID: 9639187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.
    Kurata Y; Ieiri I; Kimura M; Morita T; Irie S; Urae A; Ohdo S; Ohtani H; Sawada Y; Higuchi S; Otsubo K
    Clin Pharmacol Ther; 2002 Aug; 72(2):209-19. PubMed ID: 12189368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
    Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S
    J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
    Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
    Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin.
    Gooderham MJ; Bolli P; Fernandez PG
    Ann Pharmacother; 1999; 33(7-8):796-9. PubMed ID: 10466907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clarithromycin on steady-state digoxin concentrations.
    Tanaka H; Matsumoto K; Ueno K; Kodama M; Yoneda K; Katayama Y; Miyatake K
    Ann Pharmacother; 2003 Feb; 37(2):178-81. PubMed ID: 12549942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the clarithromycin-digoxin interaction in elderly patients.
    Zapater P; Reus S; Tello A; Torrús D; Pérez-Mateo M; Horga JF
    J Antimicrob Chemother; 2002 Oct; 50(4):601-6. PubMed ID: 12356809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin-associated digoxin toxicity in the elderly.
    Brown BA; Wallace RJ; Griffith DE; Warden R
    Clin Infect Dis; 1997 Jan; 24(1):92-3. PubMed ID: 8994761
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature.
    Lee CY; Marcotte F; Giraldeau G; Koren G; Juneau M; Tardif JC
    Can J Cardiol; 2011; 27(6):870.e15-6. PubMed ID: 21907534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin.
    van der Velden W; Huussen J; Ter Laak H; de Sévaux R
    Neth J Med; 2008 May; 66(5):204-6. PubMed ID: 18490798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin toxicity secondary to clarithromycin therapy.
    Nawarskas JJ; McCarthy DM; Spinler SA
    Ann Pharmacother; 1997; 31(7-8):864-6. PubMed ID: 9220047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: clarithromycin-digoxin interaction.
    Juurlink DN; Ito S
    Ann Pharmacother; 1999 Dec; 33(12):1375-6. PubMed ID: 10630847
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
    Caspi O; Zylber-Katz E; Gotsman O; Wolf DG; Caraco Y
    Ther Drug Monit; 1997 Oct; 19(5):510-5. PubMed ID: 9357092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.